141 related articles for article (PubMed ID: 37537511)
21. Postoperative radiotherapy for patients with invasive cervical cancer following treatment with simple hysterectomy.
Chen SW; Liang JA; Yang SN; Lin FJ
Jpn J Clin Oncol; 2003 Sep; 33(9):477-81. PubMed ID: 14594942
[TBL] [Abstract][Full Text] [Related]
22. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy.
Mundt AJ; Mell LK; Roeske JC
Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1354-60. PubMed ID: 12873680
[TBL] [Abstract][Full Text] [Related]
23. Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.
Turner BC; Knisely JP; Kacinski BM; Haffty BG; Gumbs AA; Roberts KB; Frank AH; Peschel RE; Rutherford TJ; Edraki B; Kohorn EI; Chambers SK; Schwartz PE; Wilson LD
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):77-84. PubMed ID: 9422561
[TBL] [Abstract][Full Text] [Related]
24. Role of vaginal brachytherapy boost following adjuvant external beam radiotherapy in cervical cancer: Turkish Society for Radiation Oncology Gynecologic Group Study (TROD 04-002).
Gultekin M; Beduk Esen CS; Balci B; Alanyali S; Akkus Yildirim B; Guler OC; Yuce Sari S; Ergen SA; Sahinler I; Alsan Cetin I; Onal C; Yildiz F; Ozsaran Z
Int J Gynecol Cancer; 2021 Feb; 31(2):185-193. PubMed ID: 32998860
[TBL] [Abstract][Full Text] [Related]
25. Definitive radiotherapy consisting of whole pelvic radiotherapy with no central shielding and CT-based intracavitary brachytherapy for cervical cancer: feasibility, toxicity, and oncologic outcomes in Japanese patients.
Kusada T; Toita T; Ariga T; Kudaka W; Maemoto H; Makino W; Ishikawa K; Heianna J; Nagai Y; Aoki Y; Murayama S
Int J Clin Oncol; 2020 Nov; 25(11):1977-1984. PubMed ID: 32852648
[TBL] [Abstract][Full Text] [Related]
26. Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: a multicenter retrospective study (KROG 13-10).
Noh JM; Park W; Kim YS; Kim JY; Kim HJ; Kim J; Kim JH; Yoon MS; Choi JH; Yoon WS; Kim JY; Huh SJ
Gynecol Oncol; 2014 Mar; 132(3):618-23. PubMed ID: 24486605
[TBL] [Abstract][Full Text] [Related]
27. Analysis of the effect of adjuvant radiotherapy on outcomes and complications after radical hysterectomy in FIGO stage IB1 cervical cancer patients with intermediate risk factors (GOTIC Study).
Nakamura K; Kitahara Y; Satoh T; Takei Y; Takano M; Nagao S; Sekiguchi I; Suzuki M
World J Surg Oncol; 2016 Jun; 14(1):173. PubMed ID: 27356862
[TBL] [Abstract][Full Text] [Related]
28. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
29. Treatment results of adjuvant pelvic radiotherapy after radical hysterectomy for low-risk Stage IB1-IIA cervical cancer.
Zhao D; Qiu H; Zhang H; Hong L; Zhang G; Xie C
Jpn J Clin Oncol; 2017 Nov; 47(11):1024-1030. PubMed ID: 28973662
[TBL] [Abstract][Full Text] [Related]
30. Initial clinical experience with intensity-modulated whole-pelvis radiation therapy in women with gynecologic malignancies.
Mundt AJ; Roeske JC; Lujan AE; Yamada SD; Waggoner SE; Fleming G; Rotmensch J
Gynecol Oncol; 2001 Sep; 82(3):456-63. PubMed ID: 11520140
[TBL] [Abstract][Full Text] [Related]
31. Operable Stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy.
Atlan D; Touboul E; Deniaud-Alexandre E; Lefranc JP; Antoine JM; Jannet D; Lhuillier P; Uzan M; Huart J; Genestie C; Antoine M; Jamali M; Ganansia V; Milliez J; Uzan S; Blondon J
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):780-93. PubMed ID: 12377330
[TBL] [Abstract][Full Text] [Related]
32. Salvage radiotherapy with or without concurrent chemotherapy for pelvic recurrence after hysterectomy alone for early-stage uterine cervical cancer.
Kim SW; Chun M; Ryu HS; Chang SJ; Kong TW; Lee EJ; Lee YH; Oh YT
Strahlenther Onkol; 2017 Jul; 193(7):534-542. PubMed ID: 28357468
[TBL] [Abstract][Full Text] [Related]
33. Clinical impact of boost irradiation to pelvic lymph node in uterine cervical cancer treated with definitive chemoradiotherapy.
Choi KH; Kim JY; Lee DS; Lee YH; Lee SW; Sung S; Park HH; Yoon SC; Hur SY; Park JS; Kim YS
Medicine (Baltimore); 2018 Apr; 97(16):e0517. PubMed ID: 29668638
[TBL] [Abstract][Full Text] [Related]
34. Postoperative radiotherapy in stage I/II endometrial cancer: retrospective analysis of 883 patients treated at the University of Florence.
Scotti V; Borghesi S; Meattini I; Saieva C; Rossi F; Petrucci A; Galardi A; Livi L; Agresti B; Fambrini M; Marchionni M; Biti G
Int J Gynecol Cancer; 2010 Dec; 20(9):1540-8. PubMed ID: 21370597
[TBL] [Abstract][Full Text] [Related]
35. Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible.
Lee TH; Song C; Kim IA; Kim JS; Kim YB; Kim K; No JH; Suh DH; Chung JB; Eom KY
Radiat Oncol; 2021 Aug; 16(1):148. PubMed ID: 34384450
[TBL] [Abstract][Full Text] [Related]
36. Postoperative elective pelvic nodal irradiation compared to prostate bed irradiation in locally advanced prostate cancer - a retrospective analysis of dose-escalated patients.
Link C; Honeck P; Makabe A; Giordano FA; Bolenz C; Schaefer J; Bohrer M; Lohr F; Wenz F; Buergy D
Radiat Oncol; 2019 Jun; 14(1):96. PubMed ID: 31174555
[TBL] [Abstract][Full Text] [Related]
37. Dosimetric planning study for the prevention of anal complications after post-operative whole pelvic radiotherapy in cervical cancer patients with hemorrhoids.
Baek JG; Kim EC; Kim SK; Jang H
Br J Radiol; 2015; 88(1056):20150223. PubMed ID: 26395671
[TBL] [Abstract][Full Text] [Related]
38. Intensity-modulated radiation therapy versus three-dimensional conformal radiation therapy with concurrent nedaplatin-based chemotherapy after radical hysterectomy for uterine cervical cancer: comparison of outcomes, complications, and dose-volume histogram parameters.
Isohashi F; Mabuchi S; Yoshioka Y; Seo Y; Suzuki O; Tamari K; Yamashita M; Unno H; Kinose Y; Kozasa K; Sumida I; Otani Y; Kimura T; Ogawa K
Radiat Oncol; 2015 Aug; 10():180. PubMed ID: 26300325
[TBL] [Abstract][Full Text] [Related]
39. Radical surgery with individualized postoperative radiation for stage IB cervical cancer: oncologic outcomes and severe complications.
Sandadi S; Tanner EJ; Khoury-Collado F; Kostolias A; Makker V; Chi DS; Sonoda Y; Alektiar KM; Barakat RR; Abu-Rustum NR
Int J Gynecol Cancer; 2013 Mar; 23(3):553-8. PubMed ID: 23392402
[TBL] [Abstract][Full Text] [Related]
40. Role of adjuvant radiotherapy after radical hysterectomy in node-negative stage IB-IIA cervical cancer with intermediate risk factors.
Tuipae S; Yanaranop M; Oniem N
J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S117-24. PubMed ID: 22619897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
